Prostate Cancer Treatment <br />Linked to Dementia Research has found that androgen deprivation therapy, a prostate cancer drug treatment, is linked to dementia <br />and Alzheimer’s. The study, conducted by JAMA network, followed over 150,000 men, aged 66 and older. The results showed that men who took ADT were at a <br />20 percent higher chance of dementia and 14 percent higher chance of Alzheimer’s. The treatment suppresses the hormones <br />that help spread the cancer. Researchers are encouraging doctors to consider the long-term effects of the treatment before giving it<br />to patients.
